XML 16 R4.htm IDEA: XBRL DOCUMENT v3.4.0.3
Condensed Consolidated Statements of Operations - USD ($)
3 Months Ended
Mar. 31, 2016
Mar. 31, 2015
Revenues $ 24,721,000 $ 34,210,000
Operating costs and expenses    
Inventor royalties 1,573,000 9,325,000
Contingent legal fees 4,109,000 4,784,000
Litigation and licensing expenses - patents 7,723,000 8,675,000
Amortization of patents 10,760,000 13,038,000
General and administrative expenses (including non-cash stock compensation expense of $1,735 for the three months ended March 31, 2016 and $3,247 for the three months ended March 31, 2015, respectively) 7,994,000 10,575,000
Research, consulting and other expenses - business development 522,000 997,000
Other expenses 1,742,000 426,000
Total operating costs and expenses 34,423,000 47,820,000
Operating loss (9,702,000) (13,610,000)
Total other income (expense) (3,000) 228,000
Loss before provision for income taxes (9,705,000) (13,382,000)
Provision for income taxes (192,000) (170,000)
Loss including noncontrolling interests in operating subsidiaries (9,897,000) (13,552,000)
Net (income) loss attributable to noncontrolling interests in operating subsidiaries (68,000) 422,000
Net loss attributable to Acacia Research Corporation (9,965,000) (13,130,000)
Net loss available to common stockholders, basic $ (9,965,000) $ (13,345,000)
Earnings Per Share, Basic and Diluted $ (0.20) $ (0.27)
Weighted Average Number of Shares Outstanding, Basic and Diluted 49,925,550 49,212,207
Common Stock, Dividends, Per Share, Cash Paid $ 0.000 $ 0.125